Center for Epidemiological Research (EPICENTER), Curitiba, Brazil.
School of Medicine, Pontificia Universidade Catolica do Parana, Curitiba, Brazil.
BMC Nephrol. 2024 Jun 4;25(1):191. doi: 10.1186/s12882-024-03588-w.
Chronic kidney disease (CKD) is a global health problem with rising prevalence, morbidity, mortality, and associated costs. Early identification and risk stratification are key to preventing progression to kidney failure. However, there is a paucity of data on practice patterns of kidney function assessment to guide the development of improvement strategies, particularly in lower-income countries.
A retrospective observational analysis was conducted in a nationwide laboratory database in Brazil. We included all adult patients with at least one serum creatinine assessment between June 2018 and May 2021. Our primary objective was to determine the proportion of patients with estimated glomerular filtration rate (eGFR) evaluations accompanied by predicted levels of urinary albumin-to-creatinine ratio (pACR) assessments within 12 months.
Out of 4,5323,332 serum creatinine measurements, 42% lacked pACR measurements within 12 months. Approximately 10.8% of tests suggested CKD, mostly at stage 3a. The proportion of serum creatinine exams paired with pACR assessment varied according to the CKD stage. Internal Medicine, Cardiology, and Obstetrics/Gynecology were the specialties requesting most of the creatinine tests. Nephrology contributed with only 1.1% of serum creatinine requests for testing.
Our findings reveal that a significant proportion of individuals with a creatinine test lack an accompanying urinary albuminuria measurement in Brazil, contrary to the recommendations of the international guidelines. Non-Nephrologists perform most kidney function evaluations, even among patients with presumable advanced CKD. This highlights the urge to incorporate in clinical practice the early detection of CKD and to encourage more collaborative multidisciplinary care to improve CKD management.
慢性肾脏病(CKD)是一个全球性的健康问题,其患病率、发病率、死亡率和相关费用都在不断上升。早期识别和风险分层是预防肾功能衰竭进展的关键。然而,关于肾功能评估的实践模式数据很少,无法为改善策略的制定提供指导,特别是在低收入国家。
本研究在巴西的一个全国性实验室数据库中进行了回顾性观察性分析。我们纳入了 2018 年 6 月至 2021 年 5 月期间至少进行过一次血清肌酐评估的所有成年患者。我们的主要目的是确定在 12 个月内,肾小球滤过率(eGFR)评估伴预测尿白蛋白/肌酐比值(pACR)评估的患者比例。
在 4532332 次血清肌酐测量中,有 42%的测量结果未在 12 个月内进行 pACR 测量。约 10.8%的检测结果提示 CKD,主要处于 3a 期。血清肌酐检查与 pACR 评估配对的比例因 CKD 分期而异。内科、心脏病学和妇产科是要求进行大多数肌酐检测的科室。肾病科仅贡献了 1.1%的血清肌酐检测请求。
我们的研究结果表明,在巴西,很大一部分进行肌酐检测的患者缺乏尿白蛋白尿检测,这与国际指南的建议相悖。非肾病医生进行了大多数肾功能评估,即使是在疑似晚期 CKD 的患者中也是如此。这突显了将 CKD 的早期检测纳入临床实践并鼓励更多协作的多学科护理以改善 CKD 管理的迫切需求。